Microfluidic Droplet Barcoding for T-Cell Activation Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting T-cell activation and correlating it with specific TCR sequences in cancer immunotherapy have low throughput, lack single-cell resolution, and struggle to identify functional TCR-APC pairs, hindering the development of effective immunotherapies.

Innovation Solution

A microfluidic platform using dual barcoding with optical and Unique Molecular Identifiers (UMIs) to profile T-cell activation in response to antigens, enabling the simultaneous monitoring and sequencing of thousands of cell pairs per second, thereby correlating activation profiles with specific TCR sequences.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used to detect T-cell activation and correlate with TCR sequences, then the process is simpler to implement, but the throughput is low and single-cell resolution is lost

Engineering Contradiction:
Improvethroughput of T-cell activation analysisVSAvoidcomplexity of microfluidic platform
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system segments the analysis process into distinct microfluidic modules: droplet generation for single-cell encapsulation, barcode incorporation for cell identification, activation monitoring for functional assessment, and sequencing integration for TCR characterization. This segmentation enables high-throughput processing while maintaining single-cell resolution through parallel independent analysis of thousands of individual droplets containing single cell pairs.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements nested barcoding where unique molecular identifiers (UMIs) are nested within droplet barcodes, which are themselves nested within the microfluidic droplet structure containing the cell pair. This multi-level nesting enables tracking of individual cells through complex processing steps while maintaining the ability to correlate activation profiles with specific TCR sequences through the hierarchical barcode structure.

Inventive Principle:
Principle #7Nested doll (Nesting)

2Measurement precision

If high-throughput microfluidic analysis is implemented, then single-cell resolution and identification of TCR-APC pairs is achieved, but the device complexity increases

Engineering Contradiction:
Improvesingle-cell resolution of T-cell activationVSAvoidcomplexity of dual barcoding system
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The microfluidic platform integrates multiple functions into a single system: droplet generation and manipulation, dual barcode incorporation and tracking, cell pair encapsulation, activation monitoring, and sequencing integration. This multi-functionality achieves high measurement precision for single-cell resolution while reducing overall system complexity by consolidating what would otherwise require multiple separate instruments and protocols.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The dual barcode system acts as an intermediary that bridges the gap between the physical cell pair encapsulation and the digital sequencing data. The barcodes mediate the correlation between optical detection of activation profiles and the molecular identification of TCR sequences, enabling precise single-cell measurement without requiring direct physical connection between monitoring and sequencing systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If conventional low-throughput methods are used, then the device complexity is lower, but the ability to identify functional TCR-APC pairs is limited

Engineering Contradiction:
Improveability to identify functional TCR-APC pairsVSAvoidthroughput of immunotherapeutic option screening
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The system performs preliminary encapsulation of cell pairs in droplets with incorporated barcodes before activation occurs. This preliminary action establishes the unique identifier for each cell pair in advance, enabling subsequent high-throughput monitoring and sequencing to efficiently identify functional TCR-APC pairs without requiring complex real-time decision-making during the activation process itself.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system implements feedback through the dual barcode system that links optical activation profiles directly to sequencing data. By monitoring activation in real-time and using the barcode information to guide subsequent sequencing steps, the system efficiently identifies functional pairs while maintaining high throughput. The feedback loop ensures that only actively interacting pairs are subjected to full sequencing analysis, optimizing resource utilization.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20230390770A1High Throughput Microfluidics for Analysis of Immune Cell Activation
Publication Date: 2023.12.07 THE GENERAL HOSPITAL CORP
  • US20230390770A1 patent drawing
  • US20230390770A1 patent drawing
  • US20230390770A1 patent drawing

AI summary

Provided herein are microfluidic platforms and methods of use thereof for generating, tracking, monitoring, and analyzing thousands of droplets per second for interactions between two or more particles, such as cells, encapsulated in individual droplets, wherein the individual droplets are uniquely identified by specific ratios of multiple different optical barcodes and at least one sequence barcode per droplet.